Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.

Authors: Krause A,Whu WZ,Xu Y,Joh J,Crystal RG,Worgall S,
Address: Department of Genetic Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
Journal: Vaccine.

Publication: 2011 Mar 3;29(11):2131-9. doi: 10.1016/j.vaccine.2010.12.087. Epub 2011 Jan 6.

abstract

Replication-deficient adenoviral (Ad) vectors are an attractive platform for a vaccine against lung infections caused by Pseudomonas aeruginosa. Ad vectors based on non-human serotypes have been developed to circumvent the problem of pre-existing anti-Ad immunity in humans. The present study analyzes the anti-P. aeruginosa systemic and lung mucosal immunity elicited by a non-human primate-based AdC7 vector expressing the outer membrane protein F (AdC7OprF) of P. aeruginosa. Intramuscular immunization of mice with AdC7OprF induced similar levels of serum and mucosal anti-OprF IgG and increased levels of anti-OprF IgA in lung epithelial lining fluid (ELF) compared to immunization with a human serotype Ad5OprF vector (p>0.05). OprF-specific INF-γ in splenic T cells stimulated with OprF-pulsed syngeneic splenic dendritic cells (DC) was similar following immunization with AdC7OprF compared to Ad5OprF (p>0.05). In contrast, OprF-specific INF-γ responses in lung T cells stimulated with either spleen or lung DC were increased following immunization with AdC7OprF compared to Ad5OprF (p<0.05). Interestingly, direct administration of AdC7OprF to the respiratory tract resulted in an increase of OprF-specific IgG in serum, OprF-specific IgG and IgA in lung ELF, and OprF-specific INF-γ in lung T-cells compared to immunization with Ad5OprF, and survival following challenge with a lethal dose of P. aeruginosa. These data demonstrate that systemic or lung mucosal immunization with an AdC7-based vaccine vector induces superior pulmonary humoral and cellular anti-transgene immunity compared to immunization with an Ad5-based vector and favors AdC7-based vectors as vaccines to induce lung mucosal immunity.

Related Articles
Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.
J Virol. 2007
Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.
Worgall S, Krause A, Qiu J, Joh J, Hackett NR, Crystal RG. J Virol. 2007 Dec; 81(24):13801-8. Epub 2007 Oct 17.
Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
J Clin Invest. 2005
Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
Worgall S, Krause A, Rivara M, Hee KK, Vintayen EV, Hackett NR, Roelvink PW, Bruder JT, Wickham TJ, Kovesdi I, et al. J Clin Invest. 2005 May; 115(5):1281-9. Epub 2005 Apr 1.
RGD Capsid Modification Enhances Mucosal Protective Immunity of a Non-human Primate Adenovirus Vector Expressing P. aeruginosa OprF.
Clin Exp Immunol. 2013
RGD Capsid Modification Enhances Mucosal Protective Immunity of a Non-human Primate Adenovirus Vector Expressing P. aeruginosa OprF.
Krause A, Whu WZ, Qiu J, Wafadari D, Hackett NR, Sharma A, Crystal RG, Worgall S. Clin Exp Immunol. 2013 Mar 13; . Epub 2013 Mar 13.
Review Pseudomonas aeruginosa antigens as potential vaccines.
FEMS Microbiol Rev. 1997
Review Pseudomonas aeruginosa antigens as potential vaccines.
Stanislavsky ES, Lam JS. FEMS Microbiol Rev. 1997 Nov; 21(3):243-77.
Review Potential of protein OprF of Pseudomonas in bivalent vaccines.
Behring Inst Mitt. 1997
Review Potential of protein OprF of Pseudomonas in bivalent vaccines.
Hancock RE, Wong R. Behring Inst Mitt. 1997 Feb; (98):283-90.
Adenovirus-based vaccine with epitopes incorporated in novel fiber sites to induce protective immunity against Pseudomonas aeruginosa.
PLoS One. 2013
Adenovirus-based vaccine with epitopes incorporated in novel fiber sites to induce protective immunity against Pseudomonas aeruginosa.
Sharma A, Krause A, Xu Y, Sung B, Wu W, Worgall S. PLoS One. 2013; 8(2):e56996. Epub 2013 Feb 20.
Review Outer membrane protein A and OprF: versatile roles in Gram-negative bacterial infections.
FEBS J. 2012
Review Outer membrane protein A and OprF: versatile roles in Gram-negative bacterial infections.
Krishnan S, Prasadarao NV. FEBS J. 2012 Mar; 279(6):919-31. Epub 2012 Feb 10.
Review Recent developments for Pseudomonas vaccines.
Hum Vaccin. 2011
Review Recent developments for Pseudomonas vaccines.
Sharma A, Krause A, Worgall S. Hum Vaccin. 2011 Oct; 7(10):999-1011. Epub 2011 Oct 1.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.